Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Free Radic Res ; 49(9): 1055-68, 2015.
Article in English | MEDLINE | ID: mdl-25968943

ABSTRACT

High fructose consumption has implicated in insulin resistance and metabolic syndrome. Fructose is a highly lipogenic sugar that has intense metabolic effects in liver. Recent evidences suggest that fructose exposure to other tissues has substantial and profound metabolic consequences predisposing toward chronic conditions such as type 2 diabetes. Since skeletal muscle is the major site for glucose utilization, in the present study we define the effects of fructose exposure on glucose utilization in skeletal muscle cells. Upon fructose exposure, the L6 skeletal muscle cells displayed diminished glucose uptake, glucose transporter type 4 (GLUT4) translocation, and impaired insulin signaling. The exposure to fructose elevated reactive oxygen species (ROS) production in L6 myotubes, accompanied by activation of the stress/inflammation markers c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase 1/2 (ERK1/2), and degradation of inhibitor of NF-κB (IκBα). We found that fructose caused impairment of glucose utilization and insulin signaling through ROS-mediated activation of JNK and ERK1/2 pathways, which was prevented in the presence of antioxidants. In conclusion, our data demonstrate that exposure to fructose induces cell-autonomous oxidative response through ROS production leading to impaired insulin signaling and attenuated glucose utilization in skeletal muscle cells.


Subject(s)
Fructose/chemistry , Glucose/metabolism , Muscle Cells/metabolism , Muscle Fibers, Skeletal/metabolism , Muscle, Skeletal/cytology , Reactive Oxygen Species/metabolism , Animals , Cell Survival , Cells, Cultured , Gene Expression Profiling , Glucose Transporter Type 4/metabolism , Hydrogen Peroxide/metabolism , I-kappa B Proteins/metabolism , Inflammation/metabolism , Insulin/metabolism , Insulin Resistance , MAP Kinase Kinase 4/metabolism , Mice , Muscle, Skeletal/metabolism , NF-KappaB Inhibitor alpha , Necrosis , Oxidative Stress , Signal Transduction , Superoxides/chemistry
2.
Bioorg Med Chem Lett ; 22(17): 5648-51, 2012 Sep 01.
Article in English | MEDLINE | ID: mdl-22840238

ABSTRACT

Peganum harmala Linn, commonly known as 'harmal' belonging to the family Zygophyllaceae, is one of the most important medicinal plants of India. In continuation of our drug development program on Indian medicinal plants we discovered antihyperglycemic activity in 4-hydroxypipecolic acid (4-HPA), isolated from the seed of P. harmala. Effect of 4-HPA on glucose uptake and glucose transporter-4 (GLUT-4) translocation was investigated in L6 skeletal muscle cell lines. Treatment with 4-HPA stimulated both glucose uptake and GLUT4 translocation from intracellular to cell surface in skeletal muscle cells in a concentration-dependent manner, which might be leading to antihyperglycemic effect.


Subject(s)
Glucose Transporter Type 4/metabolism , Glucose/metabolism , Hypoglycemic Agents/pharmacology , Muscle, Skeletal/metabolism , Pipecolic Acids/pharmacology , Animals , Biological Transport/drug effects , Cell Line , Hypoglycemic Agents/isolation & purification , Insulin/metabolism , Muscle, Skeletal/cytology , Peganum/chemistry , Pipecolic Acids/isolation & purification , Rats
3.
Bioorg Med Chem ; 20(6): 2172-9, 2012 Mar 15.
Article in English | MEDLINE | ID: mdl-22341243

ABSTRACT

A series of propiophenone derivatives (6-23) have been synthesized and evaluated for their in vivo antihyperglycemic activities in sucrose loaded model (SLM), sucrose challenged streptozotocin (STZ-S) induced diabetic rat model and C57BL/KsJ db/db diabetic mice model. Compound 15 and 16 were emerged as potent antihyperglycemics and lipid lowering agents. These compounds (15, 16) further validate the potency by reducing body weight and food intake in db/db mice model. Possible mechanism of action for the propiophenone derivatives was established by the evaluation in various in vitro models. Interestingly some of the compounds were efficiently inhibiting PTP-1B.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/therapeutic use , Propiophenones/chemistry , Propiophenones/therapeutic use , Weight Loss/drug effects , Animals , Blood Glucose/drug effects , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/metabolism , Eating/drug effects , Hypoglycemic Agents/chemical synthesis , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/chemical synthesis , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/pharmacology , Hypolipidemic Agents/therapeutic use , Lipids/blood , Male , Mice , Mice, Inbred C57BL , Propiophenones/chemical synthesis , Propiophenones/pharmacology , Protein Tyrosine Phosphatase, Non-Receptor Type 1/antagonists & inhibitors , Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism , Rats , Rats, Sprague-Dawley , Rats, Wistar , Streptozocin
4.
Bioorg Med Chem ; 18(11): 4138-48, 2010 Jun 01.
Article in English | MEDLINE | ID: mdl-20471838

ABSTRACT

A series of 2,4-disubstituted polyhydroquinoline were synthesized and evaluated for their in vivo antihyperglycemic as well as antidyslipidemic activities. Several synthesized compounds have exhibited promising in vivo antihyperglycemic in SLM, STZ-S, and db/db mice model along with significant lipid and TG modulating activity. All these compounds were evaluated in various in vitro models of diabetes to know the possible mechanism of their antihyperglycemic action. Interestingly, compounds 3a-r (diaryl substitution) have exhibited promising protein-tyrosine phosphatase 1B (PTP1B) inhibitory activity whereas, compounds 5a-d (acid substituted) have shown significant glycogen phosphorylase activity.


Subject(s)
Dyslipidemias/drug therapy , Hypoglycemic Agents/chemical synthesis , Quinolines/chemical synthesis , Animals , Diabetes Mellitus, Experimental/drug therapy , Drug Design , Glycogen Phosphorylase/antagonists & inhibitors , Hypoglycemic Agents/pharmacology , Mice , Mice, Inbred Strains , Protein Tyrosine Phosphatase, Non-Receptor Type 1/antagonists & inhibitors , Quinolines/pharmacology
5.
Bioorg Med Chem ; 17(14): 5285-92, 2009 Jul 15.
Article in English | MEDLINE | ID: mdl-19500993

ABSTRACT

We have designed 1,3-disubstituted-5-membered heteroaromatic ring system as a common core motif from known anti-hyperglycemic agents. Designed compounds were synthesized and screened for in vivo anti-hyperglycemic activity in sucrose loaded model (SLM), sucrose-challenged streptozotocin-induced diabetic rat model (STZ-S) as well as db/db mice model. Some of the synthesized compounds showed promising in vivo anti-hyperglycemic as well as moderate lipid lowering activity. Synthesized Compounds were screened in various in vitro models of type-2 diabeties such as DPP-4, PTP1B and PPARgamma to know the mechanism of their anti-hyperglycemic action. None of the synthesized compounds showed DPP-4 inhibitory as well as PPARgamma activity. These compounds have shown promising PTP-1B inhibitory activity there by revealing that compounds exhibit anti-diabetic activity by PTP1B pathway.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/therapeutic use , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/therapeutic use , Isoxazoles/chemistry , Isoxazoles/therapeutic use , Animals , Blood Glucose/analysis , Blood Glucose/metabolism , Cholesterol/analysis , Cholesterol/metabolism , Dose-Response Relationship, Drug , Hypoglycemic Agents/chemical synthesis , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/chemical synthesis , Hypolipidemic Agents/pharmacology , Isoxazoles/chemical synthesis , Isoxazoles/pharmacology , Male , Mice , Mice, Inbred C57BL , PPAR gamma/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism , Rats , Rats, Sprague-Dawley , Rats, Wistar , Streptozocin , Sucrose/administration & dosage , Triglycerides/analysis , Triglycerides/metabolism
6.
Folia Microbiol (Praha) ; 50(5): 448-52, 2005.
Article in English | MEDLINE | ID: mdl-16475506

ABSTRACT

An immunofluorescence assay for direct detection of V. cholerae O1 was developed using polyclonal antibodies raised against outer membrane proteins (OMPs) of V. cholerae O1. Production of OMPs varied with growth media used; maximum production was found in tryptic soy broth. The detection system was specific because no cross-reactivity was observed with other bacteria including V. cholerae O139, E. coli, S. dysenteriae and Salmonella enterica subsp. enterica serovar Typhi. The technique was able to detect 240 CFU/mL of V. cholerae O1 suspended in phosphate-buffered saline. The assay coupled with bacterial enrichment in APW for 6 h detected as few as 5 CFU of V. cholerae in spiked samples. Moreover, a 2-h incubation of enriched bacterial cells in 0.1% yeast extract with 10 ppm nalidixic acid enhanced the bacterial size and helped in morphological identification of V. cholerae. Among 32 potable water samples from afflicted hand pumps and wells collected from a cholera-plagued area 12 were found to be contaminated with V. cholerae by immunofluorescence assay as well as by conventional culture methods. The proposed method could thus be employed in environmental surveillance of V. cholerae O1.


Subject(s)
Fluorescent Antibody Technique, Direct/methods , Vibrio cholerae O1/isolation & purification , Water Microbiology , Antibodies, Bacterial , Antigens, Bacterial/immunology , Antigens, Bacterial/isolation & purification , Bacterial Outer Membrane Proteins/immunology , Bacterial Outer Membrane Proteins/isolation & purification , Cross Reactions , Culture Media/chemistry , Escherichia coli/immunology , Fresh Water/microbiology , Population Surveillance , Salmonella typhi/immunology , Sensitivity and Specificity , Shigella dysenteriae/immunology , Vibrio cholerae O1/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...